Avanos Medical (AVNS) Raw Materials (2014 - 2026)

Avanos Medical's Raw Materials history runs 13 years deep, the most recent figure standing at $4.0 million for Q1 2026.

• In Q1 2026, Raw Materials fell 89.3% year-over-year to $4.0 million; the TTM figure through Mar 2026 stood at $4.0 million (down 89.3% YoY), while the FY2025 annual figure was $4.1 million, up 41.38% from the prior year.
• Raw Materials came in at $4.0 million for Q1 2026 at Avanos Medical, down from $4.1 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $57.0 million in Q1 2023 to a low of $2.9 million in Q4 2024.
• A 5-year average of $27.0 million and a median of $36.7 million in 2022 frame the typical range for Raw Materials.
• On a YoY basis, Raw Materials climbed as much as 1403.03% in 2024 and fell as far as 94.23% in 2024.
• Avanos Medical's Raw Materials stood at $36.7 million in 2022, then jumped by 37.06% to $50.3 million in 2023, then slumped by 94.23% to $2.9 million in 2024, then jumped by 41.38% to $4.1 million in 2025, then slipped by 2.44% to $4.0 million in 2026.
• According to Business Quant data, Raw Materials over the past three periods registered $4.0 million, $4.1 million, and $4.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison